Results
1 -
10 of
89Marie Wehenkel, Jin Tae Hong and Kyung Bo Kim.
Proteasome modulators: essential chemical genetic tools for understanding human diseases, Mol. Biosyst., 2008, 4, 280. Sylvain Aubry, Kaname Sasaki, Laure Eloy, Geneviève Aubert, Pascal Retailleau, Thierry Cresteil and David Crich.
Exploring the potential of the β-thiolactones in bioorganic chemistry, Org. Biomol. Chem., 2011, 9, 7134. Kyung Bo Kim and Craig M. Crews.
From epoxomicin to carfilzomib: chemistry, biology, and medical outcomes, Nat. Prod. Rep., 2013, 30, 600. Molecular Mechanisms of the Cardiotoxicity of the Proteasomal-Targeted Drugs Bortezomib and Carfilzomib, Cardiovascular Toxicology Carfilzomib combined with suberanilohydroxamic acid (SAHA) synergistically promotes endoplasmic reticulum stress in non-small cell lung cancer cell lines, Journal of Cancer Research and Clinical Oncology Novel Proteasome Inhibitors, Advances in Biology and Therapy of Multiple Myeloma Treatment of Patients in Third Relapse and Beyond Including Double-Refractory Disease, Personalized Therapy for Multiple Myeloma Proteasome Inhibitors in the Treatment of Multiple Myeloma and AL Amyloidosis, Resistance to Proteasome Inhibitors in Cancer